Effect of neural stem cells on apoptosis of PC12 cells induced by serum deprivation

Biotechnology Progress

Volumn 23, Issue 4, 2007, Pages 952-957

  Li, Xiangqin ^a   Liu, Tianqing ^a   Song, Kedong ^a   Guan, Shui ^a   Zhu, Leilei ^a   Ge, Dan ^a   Cui, Zhanfeng ^b  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; NEUROLOGY; NUTRITION; PROTEINS; TRANSPLANTATION (SURGICAL);

NEURODEGENERATIVE DISEASES; NUTRIENT FACTORS; PARKINSON'S DISEASE (PD);

CELL DEATH;

DOPAMINE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; CHEMISTRY; COCULTURE; CULTURE MEDIUM; CYTOLOGY; METABOLISM; NERVE CELL; RAT; STEM CELL; TIME;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; DOPAMINE; NEURONS; PC12 CELLS; RATS; STEM CELLS; TIME FACTORS;

EID: 34547856670     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp070060+     Document Type: Article

References (38)

1. Rijk de, M. C.; Tzourio, C.; Breteler, M. M.; Dartigues, J. F.; Amaducci, L.; Lopez-Pousa, S.; Manubens-Bertran, I. M.; Alperovitch, A.; Rocca, W. A. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J. Neurol. Neurosurg. Psych. 1997, 62, 10-15.
2. Bower, J. H.; Maraganore, D. M.; McDonnell, S. K.; Rocca, W. A. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov. Disord. 2000, 15 (5), 819-825.
3. Singer, E. Social costs of Parkinson's disease. J. Chronic Dis. 1973, 26 (4), 243-254.
4. Rubinstein, L. M.; Chrischilles, E. A.; Voelker, M. D. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Phamacoeconomics 1997, 12 (4), 486-498.
5. Parashos, S. A.; Maraganore, D. M.; O'Brien, P. C.; Rocca, W. A. Medical services utilization and prognosis in Parkinson's disease: a population-based study. Mayo Clin. Proc. 2002, 77 (9), 918-925.
6. Van den Eeeden, S. K.; Nelson, L. M.; Tanner, C. M. First year resource utilization among Parkinson's disease patients and matched controls in a managed care setting. Neurology 1998, 50, A374.
7. Hagell, P.; Nordling, S.; Reimer, J.; Grabowski, M.; Persson, U. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov. Disord 2002, 17 (6), 1213-1220.
8. Pressley, J. C.; Louis, E. D.; Tang, M.-x.; Cote, L.; Cohen, P. D.; Glied, S.; Mayeux, R. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003, 60 (1), 87-93.
9. Mochizuki, H.; Mori, H.; Mizuno, Y. Apoptosis in neuronal generative disorders. J. Neural Transm. 1997, 50 (Suppl), 25-40.
10. Mochizuki, H.; Mori, H.; Mizuno, Y. Apoptosis in neurode generative disorders. J. Neural Transm. 1997, 50 (Suppl), 105-140.
11. Tompkins, M. M.; Basgall, E. J.; Zamrini, E.; Hill, W. D. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Pathology 1997, 150 (1), 119-131.
12. Olanow, C. W.; Watts, R. L.; Koller, W. C. An algorithm for the management of Parkinson's disease: treatment guidelines. Neurology 2001, 56 (Suppl 5), S1-S88.
13. Lang, A. E.; Lees, A. Management of Parkinson's disease: an evidence-based review. Mov. Disord. 2002, 17 (Suppl 4), S1-S166.
14. Italian Neurological Society; Italian Society of Clinical Neurophysiology. Guidelines for the treatment of Parkinson's Disease 2002. Neurol. Sci. 2003, 24 (Suppl 3), S157-S164.
15. Cosentino, M.; Martignoni, E.; Michielotto, D.; Calandrella, D.; Riboldazzi, G.; Pacchetti, C.; Frigo, G.; Nappi, G.; Lecchini, S. Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy. BMC Health Serv. Res. 2005, 5 (1), 26.
16. Armstrong, R. J.; Harrower, T. P.; Hurelbrink, C. B.; McLaughin, M.; Ratcliffe, E. L.; Tyers, P.; Richards, A.; Dunnett, S. B.; Rosser, A. E.; Barker, R. A. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells. Neuroscience 2001, 106 (1), 201-216.
17. Arnhold, S.; Lenartz, D.; Kruttwig, K.; Klinz, F. J.; Kolossov, E.; Nescheler, I.; Sturm, V.; Andressen, C.; Addicks, K. Differentiation of green fluorescent protein-labeled embryonic stem cell-derived neural precursor cells into Thy-1-positive neurons and glia after transplantation into adult rat striatum. J. Neurosurg. 2000, 93 (6), 1026-1032.
18. Lu, P.; lones, L. L.; Snyder, E. Y.; Tuszynski, M. H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 2003, 181 (2), 115-129.
19. Fricker, R. A.; Carpenter, M. k.; Winkler, C.; Greco, C. et al. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. 1999, 19 (14), 5990-6005.
20. Brüstle, O.; Choudhary, K.; Karram, K.; Hüttner, A.; Murray, K.; Dubois-Dalcq, M.; McKay, R. D. G. Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Nat. Biotechnol. 1998, 16 (11), 1040-1044.
21. Martens, D. I.; Tropepe, V.; Kooy, D. V. D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone. J. Neurosci. 2000, 20 (3), 1085-1095.
22. Yuen, E. C.; Mobley, W. C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 1996, 40 (3), 346-354.
23. Gash, D. M.; Zhang, Z.; Gerhardt, G. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 1998, 44 (Suppl 3), 121-125.
24. Akerud, P.; Alberch, J.; Eketjall, S.; Wagner, J.; Arenas, E. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J. Neurochem. 1999, 73 (1), 70-78.
25. Kearns, C. M.; Gash, D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 1995, 672 (1-2), 104-111.
26. Schumm, M. A.; Castellanos, D. A.; Frydel, B. R.; Sagen, I. Direct cell-cell contact required for neurotrophic effect of chromaffin cells on neural progenitor cells. Dev. Brain Res. 2003, 146 (1-2), 1-13.
27. Lladó, J.; Haenggeli, C.; Maragakis, N. J.; Snyder, E. Y.; Rothstein, J. D. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol. Cell Neurosci. 2004, 27 (3), 322-331.
28. Ford, M. C.; Bertram, J. P.; Hynes, S. R.; Michaud, M.; Li, Q.; Young, M.; Segal, S. S.; Madri, J. A.; Lavik, E. B. A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (8), 2512-2517.
29. Shafer, T. I.; Atchison, W. D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: A model for neurotoxicological studies. Neurotoxicology 1991, 12 (3), 473-492.
30. Hartley, A.; Stone, J. M.; Heron, C.; Cooper, J. M.; Schapira, A. H. V. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease. J. Neurochem. 1994, 63 (5), 1987-1990.
31. Macdonald, N. J.; Perez-Polo, J. R.; Bennett, A. D.; Taglialatela, G. NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B. J. Neurosci. Res. 1999, 57 (2), 219-226.
32. Li, X.-q.; Liu, T.-q.; Song, K.-d.; Yao, L.-s.; Ge, D.; Bao, C.-y.; Ma, X.-h.; Cui, Z.-f. Culture of neural stem cells in calcium alginate beads. Biotechnol. Prog. 2006, 22 (6), 1083-1089.
33. Rydel, R. E.; Greene, L. A. Acidic and basic fibroblast growth factors promote stable neurite outgrowth and neuronal differentiation in cultures PC12 cells. J. Neurosci. 1987, 7 (11), 3639-3653.
34. Rukenstein, A.; Rydel, R. E.; Greene, L. A. Multiple agents rescue PC12 cells from serum-free cell death by translation and transcription-independent mechanisms. J. Neurosci. 1991, 11 (8), 2552-2563.
35. Kavalkovich, K. W.; Boynton, R. E.; Murphy, J. M.; Barry, F. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell Dev. Biol. Anim. 2002, 38 (8), 457-466.
36. Strem, B. M.; Hicok, K. C.; Zhu, M.; Wulur, I.; Alfonso, Z.; Schreiber, R. E.; Fraser, J. K.; Hedrick, M. H. Multipotential differentiation of adipose tissue-derived stem cells. Keio J. Med. 2005, 54 (3), 132-141.
37. Maguire, T.; Novik, E.; Schloss, R.; Yarmush, M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol. Bioeng. 2006, 93 (3), 581-591.
38. Nakajima, K.; Hida, H.; Shimano, Y,; Fujimoto, I.; Hashitani, t.; Kumazaki, M.; Sukurai, T.; Nishino, H. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DA energic neurons. Brain Res. 2001, 916 (1-2), 76-84.